Microbiota metabolite butyrate alleviates intestinal inflammation associated with enhanced autophagy-related signaling in DSS-induced colitis
Qingyi Mao, Beibei Lin, Wenluo Zhang, Yu Zhang, Yue Lei, Zhou Zhang, Mengque Xu · 2026
Read Microbiota metabolite butyrate alleviates intestinal inflammation associated with enhanced autophagy-related signaling in DSS-induced colitis by Qingyi Mao, Beibei Lin, Wenluo Zhang, Yu Zhang, Yue Lei, Zhou Zhang, Mengque Xu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13318598.txt.
Description
Qingyi Mao and colleagues report a 2026 study of butyrate, a compound made by gut bacteria, in bowel inflammation resembling human inflammatory bowel disease. Stool from patients and healthy people was compared first, then mice with chemically induced colitis received sodium butyrate by mouth.
Patient stool held far less butyric acid, at 134.5 against 605.9 in the healthy comparison reported, and fewer butyrate-making bacteria such as Faecalibacterium. In mice, treatment shifted gut microbes, strengthened the bowel wall lining, and made colitis milder, while markers of the cell-cleaning process called autophagy rose. Blocking that process with a drug largely removed the protection, tying the benefit to stronger autophagy signalling in the gut.
Catalog record
| CREATOR | Qingyi Mao, Beibei Lin, Wenluo Zhang, Yu Zhang, Yue Lei, Zhou Zhang, Mengque Xu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44077 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |